Real-world Outcomes of Third-Line Immune Checkpoint Inhibitors Versus Irinotecan-Based Chemotherapy in Patients with Advanced Gastric Cancer: a Korean, Multicenter Study (KCSG ST22-06)
BMC Cancer（2024）
Key words
Gastric cancer,Third-line treatment,Irinotecan,Nivolumab,Pembrolizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined